Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sensex falls 50 points, Nifty above 24,050; Eternal, Sun Pharma, TechM rise 1% - The Economic Times
Sensex falls 50 points, Nifty above 24,050; Eternal, Sun Pharma, TechM rise 1%The Economic Times
Sun Pharmaceutical Industries Ltd spurts 1.19%, rises for fifth straight session
Sun Pharmaceutical Industries Ltd is quoting at Rs 1885, up 1.19% on the day as on 12:44 IST on the NSE. The stock is up 13.44% in last one year as compared to a 4.38% drop in NIFTY and a 15.7% drop in the Nifty Pharma.
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top Gainers - Equitymaster
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top GainersEquitymaster
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top Gainers - Equitymaster
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top GainersEquitymaster
Stocks to watch: Sun Pharma, Nestle India, Bharat Forge among shares in focus today; check list here
Stock market today: On Friday, the Sensex fell 607.08 points, or 0.78%, to finish at 76,802.90, while the Nifty 50 slipped 154.90 points, or 0.64%, to settle at 24,013.10.
Buy or sell: Gift Nifty signals gap-up start, Vaishali Parekh recommends three stocks to buy today
Buy or sell: Vaishali Parekh recommends three stocks to buy today — Lenskart, Hindalco Industries, and HDFC Life
Hindalco appoints Kapil Agrawal as CEO (Designate) for copper business; Rohit Pathak to move to new role
Hindalco Industries has appointed Kapil Agrawal as CEO (Designate) – Copper with effect from November 1, 2026. He will take over as CEO of the Copper business from March 1, 2027, succeeding Rohit Pathak, who will transition to a new role within the Aditya Birla Group.
Sun Pharmaceutical among 5 Nifty stocks showing bullish RSI upswing
Five Nifty50 stocks featured in the RSI Trending Up scan on June 17 after showing improving momentum. The RSI moved above the 50 mark from lower levels, signalling strengthening price action, improving sentiment and potential short-term buying opportunities for traders tracking bullish technical setups.
AB Group reaffirms bet on Voda Idea with ₹4,730 Cr infusion
Vodafone Idea shareholders approved a ₹4,730-crore investment from the Aditya Birla Group via preferential allotment of warrants, increasing AB Group's stake to around 13%. Chairman Kumar Mangalam Birla stated the company's focus now shifts to execution across operations, customer service, and network expansion. This capital infusion will support capital expenditure and loan repayment, reinforcing Vi's financial health.
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain bullish on Akums Drugs and Aditya Birla Sun Life AMC after strong technical breakouts, rising volumes and improving momentum indicators.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.